elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34973750-134D5E44-EEDB-4732-B2EA-33A8AD462171
Q34973750-134D5E44-EEDB-4732-B2EA-33A8AD462171
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-134D5E44-EEDB-4732-B2EA-33A8AD462171
Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents
P2860
Q34973750-134D5E44-EEDB-4732-B2EA-33A8AD462171
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-134D5E44-EEDB-4732-B2EA-33A8AD462171
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a824c796b2dbfd78ecfc3a91a09bfb8e11027052
P2860
Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects.